Dashboard
Manage Tickers

FEMYFEMASYS INC

Nasdaq femasys.com


$ 1.06 $ -0.03 (-2.75 %)    

Monday, 19-Aug-2024 15:57:20 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 481.15 $ 6.24 (1.31 %)
DIA $ 409.09 $ 2.37 (0.58 %)
SPY $ 559.11 $ 5.30 (0.96 %)
TLT $ 97.90 $ 0.45 (0.46 %)
GLD $ 231.62 $ -0.38 (-0.16 %)
$ 1.06
$ 1.07
$ 1.05 x 200
-- x --
$ 1.06 - $ 1.07
$ 0.25 - $ 4.75
62,054
na
23.55M
$ 0.16
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 03-28-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-30-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-10-2022 06-30-2022 10-Q
10 05-11-2022 03-31-2022 10-Q
11 03-24-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-11-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

chardan-capital-maintains-buy-on-femasys-lowers-price-target-to-10
Chardan Capital Maintains Buy on Femasys, ...
08/14/2024 10:38:41

Chardan Capital analyst Keay Nakae maintains Femasys (NASDAQ:FEMY) with a Buy and lowers the price target from $12 to $10.

hc-wainwright--co-maintains-buy-on-femasys-lowers-price-target-to-12
HC Wainwright & Co. Maintains Buy on Femas...
08/09/2024 10:24:53

HC Wainwright & Co. analyst Emily Bodnar maintains Femasys (NASDAQ:FEMY) with a Buy and lowers the price target from $13...

femasys-q2-2024-eps-021
Femasys Q2 2024 EPS $(0.21)
08/08/2024 12:42:53

Core News & Articles
Dow Jumps Over 300 Points; Zapp Electric V...
06/20/2024 18:35:07

why-jabil-shares-are-trading-lower-by-8-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Jabil Shares Are Trading Lower By 8%? ...
06/20/2024 17:26:29

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
06/20/2024 16:32:10

gold-rises-1-accenture-shares-surge-after-q3-results
Gold Rises 1%; Accenture Shares Surge Afte...
06/20/2024 16:00:55

deep-dive-into-femasys-stock-analyst-perspectives-4-ratings
Deep Dive Into Femasys Stock: Analyst Pers...
06/20/2024 16:00:13

hc-wainwright--co-reiterates-buy-on-femasys-maintains-13-price-target
HC Wainwright & Co. Reiterates Buy on Fema...
06/20/2024 15:34:47

HC Wainwright & Co. analyst Emily Bodnar reiterates Femasys (NASDAQ:FEMY) with a Buy and maintains $13 price target.

femasys-receives-ce-mark-approval-from-the-eu-mdr-for-its-femaseed-femvue-femcerv-and-femcath-products
Femasys Receives CE Mark Approval From The...
06/20/2024 12:34:47

hc-wainwright--co-reiterates-buy-on-femasys-maintains-13-price-target
HC Wainwright & Co. Reiterates Buy on Fema...
05/09/2024 17:40:40

HC Wainwright & Co. analyst Emily Bodnar reiterates Femasys (NASDAQ:FEMY) with a Buy and maintains $13 price target.

femasys-q1-2024-gaap-eps-017-beats-019-estimate-sales-271140k-miss-776500k-estimate
Femasys Q1 2024 GAAP EPS $(0.17) Beats $(0...
05/09/2024 12:41:08

Femasys (NASDAQ:FEMY) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10...

chardan-capital-maintains-buy-on-femasys-maintains-12-price-target
Chardan Capital Maintains Buy on Femasys, ...
04/01/2024 12:25:20

Chardan Capital analyst Keay Nakae maintains Femasys (NASDAQ:FEMY) with a Buy and maintains $12 price target.

hc-wainwright--co-maintains-buy-on-femasys-raises-price-target-to-12
HC Wainwright & Co. Maintains Buy on Femas...
04/01/2024 10:43:45

HC Wainwright & Co. analyst Emily Bodnar maintains Femasys (NASDAQ:FEMY) with a Buy and raises the price target from $10...

femasys-q4-eps-019-beats-021-estimate-sales-21311k-miss-24000k-estimate
Femasys Q4 EPS $(0.19) Beats $(0.21) Estim...
03/29/2024 03:38:55

Femasys (NASDAQ:FEMY) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.21) by 9....

chardan-capital-reiterates-buy-on-femasys-maintains-12-price-target
Chardan Capital Reiterates Buy on Femasys,...
03/21/2024 16:54:09

Chardan Capital analyst Keay Nakae reiterates Femasys (NASDAQ:FEMY) with a Buy and maintains $12 price target.

hc-wainwright--co-reiterates-buy-on-femasys-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Fema...
03/21/2024 10:29:26

HC Wainwright & Co. analyst Emily Bodnar reiterates Femasys (NASDAQ:FEMY) with a Buy and maintains $10 price target.

femasys-announces-topline-data-from-pivotal-trial-for-femaseed-for-treatment-of-infertility-says-in-the-severe-male-factor-cohort-findings-show-24-of-women-became-pregnant-after-femaseed-femaseed-pregnancy-rate-by-cycle-was-more-than-double-historic-intrauterine-insemination-rate
Femasys Announces Topline Data From Pivota...
03/20/2024 12:18:26

femasys-completes-first-in-office-commercial-procedure-with-femaseed-infertility-solution
Femasys Completes First In-Office Commerci...
03/06/2024 14:02:20

femasys-highlights-its-femaseed-product-says-it-is-expected-to-serve-as-a-first-line-therapeutic-option-that-is-substantially-lower-cost-with-significantly-less-risk-than-assisted-reproductive-methods
Femasys Highlights Its FemaSeed Product, S...
02/28/2024 14:03:53

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION